Effect of switching from natalizumab to moderate- vs high-efficacy DMT in clinical practice

OBJECTIVE: To assess the real-world comparative effectiveness of switching from natalizumab (NTZ) to a moderate-efficacy (Mod) disease-modifying therapy (DMT) vs high-efficacy therapy (HET) in patients with multiple sclerosis (MS). METHODS: Patients discontinuing NTZ at two MS centers (n = 556) who...

Descripción completa

Detalles Bibliográficos
Autores principales: Hersh, Carrie M., Harris, Haleigh, Conway, Devon, Hua, Le H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837445/
https://www.ncbi.nlm.nih.gov/pubmed/33510948
http://dx.doi.org/10.1212/CPJ.0000000000000809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837445/
https://www.ncbi.nlm.nih.gov/pubmed/33510948
http://dx.doi.org/10.1212/CPJ.0000000000000809

Ejemplares similares